Literature DB >> 16452179

Rapid alteration of microRNA levels by histone deacetylase inhibition.

Gary K Scott1, Michael D Mattie, Crystal E Berger, Stephen C Benz, Christopher C Benz.   

Abstract

Improved understanding of the molecular mechanisms by which small-molecule inhibitors of histone deacetylases (HDAC) induce programs, such as cellular differentiation and apoptosis, would undoubtedly assist their clinical development as anticancer agents. As modulators of gene transcript levels, HDAC inhibitors (HDACi) typically affect only 5% to 10% of actively transcribed genes with approximately as many mRNA transcripts being up-regulated as down-regulated. Using microRNA (miRNA) array analysis, we report rapid alteration of miRNA levels in response to the potent hydroxamic acid HDACi LAQ824 in the breast cancer cell line SKBr3. Within 5 hours of exposure to a proapoptotic dose of LAQ824, significant changes were measured in 40% of the >60 different miRNA species expressed in SKBr3 cells with 22 miRNA species down-regulated and 5 miRNAs up-regulated. To explore a potential functional link between HDACi induced mRNA up-regulation and miRNA down-regulation, antisense experiments were done against miR-27a and miR-27b, both abundantly expressed and down-regulated in SKBr3 cells by LAQ824. Correlating a set of genes previously determined by cDNA array analysis to be rapidly up-regulated by LAQ824 in SKBr3 with a database of potential 3' untranslated region miRNA binding elements, two genes containing putative miR-27 anchor elements were identified as transcriptionally up-regulated following miR-27 antisense transfection, ZBTB10/RINZF, a Sp1 repressor, and RYBP/DEDAF, an apoptotic facilitator. These findings emphasize the importance of post-transcriptional mRNA regulation by HDACi in addition to their established effects on promoter-driven gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452179     DOI: 10.1158/0008-5472.CAN-05-3632

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  187 in total

1.  miRNAs in human cancer.

Authors:  Xiaomin Zhong; George Coukos; Lin Zhang
Journal:  Methods Mol Biol       Date:  2012

Review 2.  Shielding the messenger (RNA): microRNA-based anticancer therapies.

Authors:  Elena Sotillo; Andrei Thomas-Tikhonenko
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

Review 3.  Histone/protein deacetylases and T-cell immune responses.

Authors:  Tatiana Akimova; Ulf H Beier; Yujie Liu; Liqing Wang; Wayne W Hancock
Journal:  Blood       Date:  2012-01-12       Impact factor: 22.113

Review 4.  Mechanisms of control of microRNA biogenesis.

Authors:  Brandi N Davis-Dusenbery; Akiko Hata
Journal:  J Biochem       Date:  2010-09-09       Impact factor: 3.387

5.  MicroRNAs, macrocontrol: regulation of miRNA processing.

Authors:  Izabella Slezak-Prochazka; Selvi Durmus; Bart-Jan Kroesen; Anke van den Berg
Journal:  RNA       Date:  2010-04-27       Impact factor: 4.942

Review 6.  Causes and consequences of microRNA dysregulation.

Authors:  Marilena V Iorio; Carlo M Croce
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

Review 7.  The interplay between microRNAs and histone deacetylases in neurological diseases.

Authors:  Megan W Bourassa; Rajiv R Ratan
Journal:  Neurochem Int       Date:  2014-03-27       Impact factor: 3.921

Review 8.  MicroRNAs: potential regulators of renal development genes that contribute to CAKUT.

Authors:  April K Marrone; Jacqueline Ho
Journal:  Pediatr Nephrol       Date:  2013-09-03       Impact factor: 3.714

9.  Sulforaphane causes a major epigenetic repression of myostatin in porcine satellite cells.

Authors:  Huitao Fan; Rui Zhang; Dawit Tesfaye; Ernst Tholen; Christian Looft; Michael Hölker; Karl Schellander; Mehmet Ulas Cinar
Journal:  Epigenetics       Date:  2012-10-23       Impact factor: 4.528

Review 10.  MicroRNAs in cancer.

Authors:  Yong Sun Lee; Anindya Dutta
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.